Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
XLS
vs
S
Swiss Market Index
XLS
Over the past 12 months, XLS has underperformed Swiss Market Index, delivering a return of -53% compared to Swiss Market Index's +8% growth.
Stocks Performance
XLS vs Swiss Market Index
Performance Gap
XLS vs Swiss Market Index
Performance By Year
XLS vs Swiss Market Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Xlife Sciences AG
Glance View
Xlife Sciences AG is a Swiss life-sciences company that helps turn research ideas into commercial products. It works with universities, hospitals, and researchers to identify promising technologies, then supports their development into new medicines, diagnostics, medical devices, and related health products. In practice, it acts as a bridge between academic research and the market. The company makes money mainly by building, backing, and helping commercialize these projects. Its income can come from ownership stakes in development-stage companies, licensing deals, milestones, royalties, and other value created when a project moves closer to clinical use or a sale. Its customers are not typical end consumers; they are mainly research partners, startups, and healthcare industry partners that need help turning science into a business. What makes Xlife Sciences different is that it focuses on early-stage biomedical projects rather than selling a single product line. The business is part investor, part developer, and part commercialization partner, so it earns returns from successful technology transfer and company building. That gives it exposure to the high-risk, high-upside part of the healthcare innovation chain.